|
CH535201A
(de)
|
1969-12-19 |
1973-03-31 |
Bristol Myers Co |
Verfahren zur Spaltung von racemischen 2-(o-Chlorphenyl)-2-methylaminocyclohexanon in die optisch-aktiven Isomeren
|
|
JPS632932A
(ja)
|
1986-06-23 |
1988-01-07 |
Teijin Ltd |
経鼻投与用粉末状組成物
|
|
USD308100S
(en)
|
1987-08-28 |
1990-05-22 |
Schering Corporation |
Nasal spray pump
|
|
US5002935A
(en)
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
|
US4994467A
(en)
|
1989-05-31 |
1991-02-19 |
Zimmerman Andrew W |
Treating autism and other developmental disorders in children with NMDA receptor antagonists
|
|
DE4312016A1
(de)
|
1993-04-13 |
1994-10-20 |
Goedecke Ag |
Stabile Ketamin-Lösungen
|
|
US5543434A
(en)
|
1994-02-25 |
1996-08-06 |
Weg; Stuart L. |
Nasal administration of ketamine to manage pain
|
|
CA2213567C
(en)
|
1995-02-24 |
2010-01-26 |
Stuart L. Weg |
Use of ketamine for facilitating detoxification and treatment of smoking addiction, and device therefor
|
|
CA2230690C
(en)
|
1995-08-30 |
2008-12-23 |
Stuart L. Weg |
Administration of ketamine to manage pain and to reduce drug dependency
|
|
USD401323S
(en)
|
1996-01-23 |
1998-11-17 |
Ing. Erich Pfeiffer Gmbh |
Medication dispensing apparatus
|
|
DE19619665C2
(de)
|
1996-05-15 |
2001-03-08 |
Goedecke Ag |
Racemattrennung von Ketamin
|
|
DE19723133A1
(de)
|
1997-06-03 |
1998-12-10 |
Caideil M P Teoranta Tourmakea |
Austragvorrichtung für Medien
|
|
AU135762S
(en)
|
1998-01-09 |
1998-11-19 |
Astrazeneca Ab |
Sprayer
|
|
USD433123S
(en)
|
1998-07-09 |
2000-10-31 |
Zeneca Limited |
Nasal spray
|
|
ATE292956T1
(de)
|
1998-07-24 |
2005-04-15 |
Seo Hong Yoo |
Klare wässrige lösungen enthaltend gallensäuren
|
|
US6176242B1
(en)
|
1999-04-30 |
2001-01-23 |
Medtronic Inc |
Method of treating manic depression by brain infusion
|
|
US6017961A
(en)
|
1999-07-08 |
2000-01-25 |
Flores; John Anthony |
Ketamine and n-butyl-p-aminobezoate in PLO
|
|
EP1103256A1
(de)
|
1999-11-26 |
2001-05-30 |
Claudius Dr. med. Böck |
Verwendung von Ketamin zur Behandlung von neuroendokriner Immundysfunktion und algogenem Psychosyndrom
|
|
AU2001291159A1
(en)
|
2000-09-20 |
2002-04-02 |
Shahinian Jr., Lee |
Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications
|
|
US6881731B1
(en)
|
2000-10-23 |
2005-04-19 |
Shanbrom Technologies, Llc |
Enhancers for microbiological disinfection
|
|
USD471973S1
(en)
|
2001-08-08 |
2003-03-18 |
N.V. Organon |
Applicator for a nasal delivery device
|
|
MXPA05000294A
(es)
|
2002-07-30 |
2005-08-19 |
Peter Migaly |
Terapia combinada para la depresion, prevencion de suicidios y varias condiciones medicas y psiquiatricas.
|
|
US7273889B2
(en)
|
2002-09-25 |
2007-09-25 |
Innovative Drug Delivery Systems, Inc. |
NMDA receptor antagonist formulation with reduced neurotoxicity
|
|
WO2004045601A1
(en)
|
2002-11-18 |
2004-06-03 |
Yaupon Therapeutics, Inc. |
Analgesic uses of norketamine and ketamine/norketamine prodrugs
|
|
US7687080B2
(en)
|
2002-11-25 |
2010-03-30 |
Taraxos Inc. |
Treatment of neuropathy
|
|
US20040214215A1
(en)
|
2003-03-07 |
2004-10-28 |
Yu Ruey J. |
Bioavailability and improved delivery of alkaline pharmaceutical drugs
|
|
US8082173B2
(en)
|
2003-05-22 |
2011-12-20 |
Cecil Kost |
Drug sample fulfillment architecture
|
|
US20040265364A1
(en)
|
2003-06-25 |
2004-12-30 |
Binnur Ozturk |
Neuropathy cream
|
|
US20050095277A1
(en)
|
2003-06-25 |
2005-05-05 |
Binnur Ozturk |
Neuropathy cream
|
|
USD544957S1
(en)
|
2005-03-23 |
2007-06-19 |
Rexam Dispensing Systems |
Nasal spray dispenser
|
|
US20060223788A1
(en)
|
2005-03-29 |
2006-10-05 |
Cathcart Clifton H |
Analgesic composition for topical use
|
|
CA111438S
(fr)
|
2005-05-23 |
2006-12-22 |
Rexam Dispensing Sys |
Pulvérisateur nasal
|
|
WO2006130098A1
(en)
|
2005-06-01 |
2006-12-07 |
Shl Medical Ab |
Device for delivering medicament
|
|
US20060276550A1
(en)
|
2005-06-03 |
2006-12-07 |
Dileep Bhagwat |
Topical compositions of ketamine and butamben and methods of their use
|
|
JP2009530385A
(ja)
|
2006-03-22 |
2009-08-27 |
マウント シナイ スクール オブ メディシン |
うつ病の治療のためのケタミンの鼻内投与
|
|
US20070256688A1
(en)
|
2006-04-21 |
2007-11-08 |
Aradigm Corporation |
Mechanical single dose intrapulmonary drug delivery devices
|
|
BRPI0711872A2
(pt)
|
2006-05-22 |
2011-12-06 |
Vanda Pharmaceuticals Inc |
tratamento para distúrbios depressivos
|
|
DE102007009888A1
(de)
|
2007-02-28 |
2008-09-04 |
Hermann, Holger Lars, Dr. |
Verwendung von S-(+)-Ketamin zur Behandlung von Depressionen
|
|
US20100095957A1
(en)
|
2007-03-02 |
2010-04-22 |
Corbco, Inc. |
Manually operated monodose nasal sprayer device
|
|
WO2008151179A2
(en)
|
2007-06-04 |
2008-12-11 |
Auspex Pharmaceuticals, Inc. |
Substituted phenethylamines
|
|
WO2009131794A1
(en)
|
2008-03-27 |
2009-10-29 |
University Of Kentucky Research Foundation |
Opioid-ketamine and norketamine codrug combinations for pain management
|
|
USD610678S1
(en)
|
2009-03-31 |
2010-02-23 |
Daikyo Seiko, Ltd. |
Syringe plunger and proximal end of a syringe barrel for a pre-filled nasal drip device
|
|
USD610253S1
(en)
|
2009-03-31 |
2010-02-16 |
Daikyo Seiko, Ltd. |
Pre-filled nasal drip device
|
|
US20110038807A1
(en)
|
2009-08-14 |
2011-02-17 |
Demitri Papolos |
Compositions and methods for treating bipolar disorder
|
|
US20120225949A1
(en)
|
2009-08-14 |
2012-09-06 |
Demitri Papalos |
Compositions and methods for treating bipolar disorder
|
|
US8846765B2
(en)
|
2010-06-15 |
2014-09-30 |
Gruenenthal Gmbh |
Pharmaceutical combination
|
|
USD699342S1
(en)
|
2011-03-09 |
2014-02-11 |
Suzuken Company Limited |
Injector
|
|
WO2013003669A2
(en)
|
2011-06-30 |
2013-01-03 |
University Of South Florida |
Compositions, methods of use, and methods of treatment
|
|
USD697201S1
(en)
|
2011-07-01 |
2014-01-07 |
R5 Pharmaceuticals Limited |
Buccal delivery device adaptor
|
|
US20130056557A1
(en)
|
2011-09-02 |
2013-03-07 |
Maggie Blair Felder |
Non-pressurized flavored liquid oxygen breath spray device
|
|
JP6296985B2
(ja)
|
2011-10-14 |
2018-03-20 |
ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
うつ病及び神経障害性疼痛の治療における（２ｒ，６ｒ）−ヒドロキシノルケタミン、（ｓ）−デヒドロノルケタミン及び他の（ｒ，ｓ）−ケタミンの立体異性デヒドロ及びヒドロキシル化代謝生成物の使用
|
|
AU2012340015B2
(en)
|
2011-11-14 |
2017-09-21 |
Alfasigma S.P.A. |
Assays for selecting a treatment regimen for a subject with depression and methods for treatment
|
|
US20130209585A1
(en)
|
2012-02-13 |
2013-08-15 |
Stanley Kim |
Topical NMDA Antagonist Formulations for the Treatment of Peripheral Neuropathy
|
|
US20130236573A1
(en)
*
|
2012-03-12 |
2013-09-12 |
Janssen Pharmaceutica Nv |
Esketamine for the treatment of treatment-refractory or treatment-resistant depression
|
|
AU2016203771A1
(en)
|
2012-03-13 |
2016-06-23 |
Janssen Pharmaceutica Nv |
Esketamine for the treatment of treatment-refractory or treatment-resistant depression
|
|
JP2015512418A
(ja)
|
2012-03-30 |
2015-04-27 |
ザ ジェネラル ホスピタル コーポレイション |
うつ病の治療におけるスコポラミンおよびケタミンを含む組成物
|
|
WO2014020155A1
(en)
|
2012-08-02 |
2014-02-06 |
Clinpharm Reform Gmbh |
Oral transmucosal adminstration forms of s-ketamine
|
|
SG11201501292UA
(en)
|
2012-08-23 |
2015-05-28 |
Stuart L Weg |
Anxiolytic composition, formulation and method of use
|
|
FR2994844B1
(fr)
|
2012-08-31 |
2015-01-02 |
Assist Publ Hopitaux De Paris |
Formulation gelifiante a base de ketamine
|
|
NZ619257A
(en)
|
2012-10-08 |
2015-07-31 |
Auckland Uniservices Ltd |
Ketamine derivatives
|
|
ES2484068B1
(es)
|
2013-02-08 |
2015-04-16 |
Ana MÍNGUEZ MARTÍ |
Una composición farmacéutica que contiene ketamina y amitriptilina
|
|
US20140263457A1
(en)
|
2013-03-15 |
2014-09-18 |
Launce R. Barber |
Child-resistant closure systems for containers
|
|
US20140263456A1
(en)
|
2013-03-15 |
2014-09-18 |
Launce R. Barber |
Child-resistant closure systems for containers
|
|
EP2983787B1
(en)
|
2013-04-12 |
2019-10-02 |
Icahn School of Medicine at Mount Sinai |
Method for treating post-traumatic stress disorder
|
|
EP3960162A1
(en)
|
2013-08-26 |
2022-03-02 |
Amorsa Therapeutics, Inc. |
Single-layer oral dose of neuro-attenuating ketamine
|
|
WO2015037248A1
(en)
|
2013-09-13 |
2015-03-19 |
National University Corporation Chiba University |
Application of r-ketamine and salt thereof as pharmaceuticals
|
|
US9569220B2
(en)
|
2013-10-06 |
2017-02-14 |
Synopsys, Inc. |
Processor branch cache with secondary branches
|
|
CN103705909A
(zh)
|
2013-12-16 |
2014-04-09 |
陈镜伊 |
一种无痛人流用药
|
|
WO2015101693A1
(es)
|
2013-12-31 |
2015-07-09 |
Servicio Andaluz De Salud |
Composiciones y preparaciones combinadas para el tratamiento de las algias orofaríngeas
|
|
US9610259B2
(en)
|
2014-01-14 |
2017-04-04 |
Children's Hospital Medical Center |
Compositions and methods for treating an autism spectrum disorder
|
|
EP3131533B1
(en)
|
2014-04-17 |
2019-06-05 |
Develco Pharma Schweiz AG |
Oral dosage form of ketamine
|
|
FR3023188B1
(fr)
|
2014-07-04 |
2016-08-19 |
Aptar France Sas |
Dispositif de distribution de produit fluide.
|
|
CA2957926A1
(en)
|
2014-08-13 |
2016-02-18 |
Janssen Pharmaceutica Nv |
Method for the treatment of depression
|
|
KR20170054470A
(ko)
|
2014-09-15 |
2017-05-17 |
얀센 파마슈티카 엔.브이. |
VAL66MET (SNP rs6265) 유전자형 특이적 투여 계획 및 우울증 치료 방법
|
|
EP3240422A1
(en)
|
2014-12-31 |
2017-11-08 |
Icahn School of Medicine at Mount Sinai |
Method of maintaining the anti-depressant effect of ketamine with lithium
|
|
CN104798728A
(zh)
|
2015-05-08 |
2015-07-29 |
南京中医药大学 |
产后抑郁动物模型的建立方法及其应用
|
|
US20160332962A1
(en)
|
2015-05-13 |
2016-11-17 |
Janssen Pharmaceutica Nv |
(s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
|
|
US20160338977A1
(en)
|
2015-05-20 |
2016-11-24 |
Janssen Pharmaceutica Nv |
Methods and kits for treating depression
|
|
AU2016288188B2
(en)
|
2015-06-27 |
2021-08-05 |
Shenox Pharmaceuticals, Llc |
Ketamine transdermal delivery system
|
|
US20180296478A1
(en)
|
2016-02-12 |
2018-10-18 |
Synergistic Therapeutics, Llc |
Sublingual antidepressant and antianxiety tablet
|
|
US20180042936A1
(en)
|
2016-03-18 |
2018-02-15 |
Genomind, Inc. |
Maintenance therapy using tianeptine
|
|
IL275482B1
(en)
|
2017-12-22 |
2025-03-01 |
Janssen Pharmaceuticals Inc |
Esketamine for the treatment of depression
|